India will not revive vaccine shipments until 2022
The authorities are focused on ramping up COVID-19 jab production ahead of an expected third wave of infections
You must be signed in to read this analysis
In this article
- Vaccine portfolio
- Production
- Covishield
- Covaxin
- Sputnik V
- Shipments
What is this?
This article is from the Oxford Analytica Daily Brief, which analyses geopolitical, economic, social, business and industrial developments on a global and regional basis, providing clients with timely, authoritative analysis every business day of the year. Find out more about the Oxford Analytica Daily Brief, or request a trial.
